Upregulation of T‑cadherin suppresses cell proliferation, migration and invasion of gastric cancer in vitro

Lin,Jianqing; Chen,Zhiyao; Huang,Zhijun; Chen,Feng; Ye,Zeyi; Lin,Shaoze; Wang,Weidong

doi:10.3892/etm.2017.5090

Upregulation of T‑cadherin suppresses cell proliferation, migration and invasion of gastric cancer in vitro

Authors:
- Jianqing Lin
- Zhiyao Chen
- Zhijun Huang
- Feng Chen
- Zeyi Ye
- Shaoze Lin
- Weidong Wang
View Affiliations

Affiliations: Department of Surgical Oncology, The Second Affiliated Hospital of Fujian Medical University, Quanzhou, Fujian 362000, P.R. China
Published online on: September 1, 2017 https://doi.org/10.3892/etm.2017.5090
Pages: 4194-4200
Copyright: © Lin et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

As a unique member of the cadherin superfamily, T‑cadherin (T‑cad) has been demonstrated to be associated with gastric cancer (GC) prognosis. To elucidate the function of T‑cad in GC in vitro, the present study firstly examined T‑cad protein expression in normal and gastric cancer tissues and cell lines, and it was demonstrated to be significantly downregulated in gastric cancer samples compared with normal samples. Control and T‑cad expression vectors were then transfected into the MGC8‑03 and AGS GC cell lines. Utilizing MTT, clonogenic, flow cytometry, wound healing and Transwell invasion assays in addition to Western blotting, the present study demonstrated that the overexpression of T‑cad suppressed GC cell growth and colony formation via cell cycle arrest at the G0/G1 phase via downregulating the expression of cyclin dependent kinase 4 and Cyclin D1. In addition, overexpression of T‑cad significantly inhibited GC cell migration and invasion by increasing E‑cadherin and decreasing Vimentin expression. These findings suggest T‑cad may be important in GC cell proliferation and metastasis and serve as a promising target for the treatment of GC in the future.

View Figures

View References

1	Piazuelo MB and Correa P: Gastric cáncer: Overview. Colomb Med (Cali). 44:192–201. 2013.PubMed/NCBI
2	Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J and Jemal A: Global cancer statistics, 2012. CA Cancer J Clin. 65:87–108. 2015. View Article : Google Scholar : PubMed/NCBI
3	Sugano K: Screening of gastric cancer in Asia. Best Pract Res Clin Gastroenterol. 29:895–905. 2015. View Article : Google Scholar : PubMed/NCBI
4	Xia P, Song CL, Liu JF, Wang D and Xu XY: Prognostic value of circulating CD133(+) cells in patients with gastric cancer. Cell Prolif. 48:311–317. 2015. View Article : Google Scholar : PubMed/NCBI
5	Gigek CO, Chen ES, Calcagno DQ, Wisnieski F, Burbano RR and Smith MA: Epigenetic mechanisms in gastric cancer. Epigenomics. 4:279–294. 2012. View Article : Google Scholar : PubMed/NCBI
6	Zhu W, Ye L, Zhang J, Yu P, Wang H, Ye Z and Tian J: PFK15, a small molecule inhibitor of PFKFB3, induces cell cycle arrest, apoptosis and inhibits invasion in gastric cancer. PLoS One. 11:e01637682016. View Article : Google Scholar : PubMed/NCBI
7	Yasui W, Sentani K, Sakamoto N, Anami K, Naito Y and Oue N: Molecular pathology of gastric cancer: Research and practice. Pathol Res Pract. 207:608–612. 2011. View Article : Google Scholar : PubMed/NCBI
8	Baniak N, Senger JL, Ahmed S, Kanthan SC and Kanthan R: Gastric biomarkers: A global review. World J Surg Oncol. 14:2122016. View Article : Google Scholar : PubMed/NCBI
9	Nagafuchi A, Tsukita S and Takeichi M: Transmembrane control of cadherin-mediated cell-cell adhesion. Semin Cell Biol. 4:175–181. 1993. View Article : Google Scholar : PubMed/NCBI
10	Takeichi M: Cadherin cell adhesion receptors as a morphogenetic regulator. Science. 251:1451–1455. 1991. View Article : Google Scholar : PubMed/NCBI
11	Wheelock MJ and Johnson KR: Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol. 19:207–235. 2003. View Article : Google Scholar : PubMed/NCBI
12	Takeichi M: Cadherins in cancer: Implications for invasion and metastasis. Curr Opin Cell Biol. 5:806–811. 1993. View Article : Google Scholar : PubMed/NCBI
13	Mayer B, Johnson JP, Leitl F, Jauch KW, Heiss MM, Schildberg FW, Birchmeier W and Funke I: E-cadherin expression in primary and metastatic gastric cancer: Down-regulation correlates with cellular dedifferentiation and glandular disintegration. Cancer Res. 53:1690–1695. 1993.PubMed/NCBI
14	Bringuier PP, Umbas R, Schaafsma HE, Karthaus HF, Debruyne FM and Schalken JA: Decreased E-cadherin immunoreactivity correlates with poor survival in patients with bladder tumors. Cancer Res. 53:3241–3245. 1993.PubMed/NCBI
15	Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, et al: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastasis. Cancer Res. 53:1696–1701. 1993.PubMed/NCBI
16	Angst BD, Marcozzi C and Magee AI: The cadherin superfamily: Diversity in form and function. J Cell Sci. 114:629–641. 2001.PubMed/NCBI
17	Takeuchi T and Ohtsuki Y: Recent progress in T-cadherin (CDH13, H-cadherin) research. Histol Histopathol. 16:1287–1293. 2001.PubMed/NCBI
18	Philippova M, Joshi MB, Kyriakakis E, Pfaff D, Erne P and Resink TJ: A guide and guard: The many faces of T-cadherin. Cell Signal. 21:1035–1044. 2009. View Article : Google Scholar : PubMed/NCBI
19	Andreeva AV and Kutuzov MA: Cadherin 13 in cancer. Genes Chromosomes Cancer. 49:775–790. 2010.PubMed/NCBI
20	Lee SW: H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer. Nat Med. 2:776–782. 1996. View Article : Google Scholar : PubMed/NCBI
21	Wang XD, Wang BE, Soriano R, Zha J, Zhang Z, Modrusan Z, Cunha GR and Gao WQ: Expression profiling of the mouse prostate after castration and hormone replacement: Implication of H-cadherin in prostate tumorigenesis. Differentiation. 75:219–234. 2007. View Article : Google Scholar : PubMed/NCBI
22	Pfaff D, Philippova M, Kyriakakis E, Maslova K, Rupp K, Buechner SA, Iezzi G, Spagnoli GC, Erne P and Resink TJ: Paradoxical effects of T-cadherin on squamous cell carcinoma: Up- and down-regulation increase xenograft growth by distinct mechanisms. J Pathol. 225:512–524. 2011. View Article : Google Scholar : PubMed/NCBI
23	Tang Y, Dai Y and Huo J: Decreased expression of T-cadherin is associated with gastric cancer prognosis. Hepatogastroenterology. 59:1294–1298. 2012.PubMed/NCBI
24	Mori Y, Matsunaga M, Abe T, Fukushige S, Miura K, Sunamura M, Shiiba K, Sato M, Nukiwa T and Horii A: Chromosome band 16q24 is frequently deleted in human gastric cancer. Br J Cancer. 80:556–562. 1999. View Article : Google Scholar : PubMed/NCBI
25	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
26	Lindblom A, Rotstein S, Skoog L, Nordenskjöld M and Larsson C: Deletions on chromosome 16 in primary familial breast carcinomas are associated with development of distant metastases. Cancer Res. 53:3707–3711. 1993.PubMed/NCBI
27	Carter BS, Ewing CM, Ward WS, Treiger BF, Aalders TW, Schalken JA, Epstein JI and Isaacs WB: Allelic loss of chromosomes 16q and 10q in human prostate cancer. Proc Natl Acad Sci USA. 87:8751–8755. 1990. View Article : Google Scholar : PubMed/NCBI
28	Chen T, Sahin A and Aldaz CM: Deletion map of chromosome 16q in ductal carcinoma in situ of the breast: Refining a putative tumor suppressor gene region. Cancer Res. 56:5605–5609. 1996.PubMed/NCBI
29	Wei B, Shi H, Lu X, Shi A, Cheng Y and Dong L: Association between the expression of T-cadherin and vascular endothelial growth factor and the prognosis of patients with gastric cancer. Mol Med Rep. 12:2075–2081. 2015. View Article : Google Scholar : PubMed/NCBI
30	Pfaff D, Philippova M, Buechner SA, Maslova K, Mathys T, Erne P and Resink TJ: T-cadherin loss induces an invasive phenotype in human keratinocytes and squamous cell carcinoma (SCC) cells in vitro and is associated with malignant transformation of cutaneous SCC in vivo. Br J Dermatol. 163:353–363. 2010. View Article : Google Scholar : PubMed/NCBI
31	Bosserhoff AK, Ellmann L, Quast AS, Eberle J, Boyle GM and Kuphal S: Loss of T-cadherin (CDH-13) regulates AKT signaling and desensitizes cells to apoptosis in melanoma. Mol Carcinog. 53:635–647. 2014.PubMed/NCBI
32	Philippova M, Pfaff D, Kyriakakis E, Buechner SA, Iezzi G, Spagnoli GC, Schoenenberger AW, Erne P and Resink TJ: T-cadherin loss promotes experimental metastasis of squamous cell carcinoma. Eur J Cancer. 49:2048–2058. 2013. View Article : Google Scholar : PubMed/NCBI
33	Ivanov D, Philippova M, Allenspach R, Erne P and Resink T: T-cadherin upregulation correlates with cell-cycle progression and promotes proliferation of vascular cells. Cardiovasc Res. 64:132–143. 2004. View Article : Google Scholar : PubMed/NCBI
34	Zhong Y, Lopez-Barcons L, Haigentz M Jr, Ling YH and Perez-Soler R: Exogenous expression of H-cadherin in CHO cells regulates contact inhibition of cell growth by inducing p21 expression. Int J Oncol. 24:1573–1579. 2004.PubMed/NCBI
35	Mukoyama Y, Zhou S, Miyachi Y and Matsuyoshi N: T-cadherin negatively regulates the proliferation of cutaneous squamous carcinoma cells. J Invest Dermatol. 124:833–838. 2005. View Article : Google Scholar : PubMed/NCBI
36	Huang ZY, Wu Y, Hedrick N and Gutmann DH: T-cadherin-mediated cell growth regulation involves G2 phase arrest and requires p21(CIP1/WAF1) expression. Mol Cell Biol. 23:566–578. 2003. View Article : Google Scholar : PubMed/NCBI
37	Hermiston ML and Gordon JI: Inflammatory bowel disease and adenomas in mice expressing a dominant negative N-cadherin. Science. 270:1203–1207. 1995. View Article : Google Scholar : PubMed/NCBI
38	Behrens J: The role of cell adhesion molecules in cancer invasion and metastasis. Breast Cancer Res Treat. 24:175–184. 1993. View Article : Google Scholar : PubMed/NCBI
39	Pecina-Slaus N: Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int. 3:172003. View Article : Google Scholar : PubMed/NCBI
40	Venza M, Visalli M, Catalano T, Biondo C, Beninati C, Teti D and Venza I: DNA methylation-induced E-cadherin silencing is correlated with the clinicopathological features of melanoma. Oncol Rep. 35:2451–2460. 2016. View Article : Google Scholar : PubMed/NCBI
41	Tamura G, Yin J, Wang S, Fleisher AS, Zou T, Abraham JM, Kong D, Smolinski KN, Wilson KT, James SP, et al: E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst. 92:569–573. 2000. View Article : Google Scholar : PubMed/NCBI
42	Hibi K, Kodera Y, Ito K, Akiyama S and Nakao A: Methylation pattern of CDH13 gene in digestive tract cancers. Br J Cancer. 91:1139–1142. 2004.PubMed/NCBI
43	Schoumacher M, Goldman RD, Louvard D and Vignjevic DM: Actin, microtubules and vimentin intermediate filaments cooperate for elongation of invadopodia. J Cell Biol. 189:541–556. 2010. View Article : Google Scholar : PubMed/NCBI